Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1798-1807
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1798
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1798
Variable | Univariate analysis | Multivariate analysis | ||||
OR | 95%CI | P value | OR | 95%CI | P value | |
Gender: Male | 1.78 | 1.34-2.36 | < 0.001 | 1.80 | 1.35-2.40 | < 0.001 |
Increasing age (continuous variable) | 1.04 | 1.02-1.06 | < 0.001 | 1.04 | 1.02-1.06 | < 0.001 |
Family history of CRC | 1.07 | 0.68-1.68 | 0.77 | 2.07 | 1.49-2.87 | < 0.001 |
No previous colonoscopy | 1.83 | 1.39-2.52 | < 0.001 | |||
Aspirin use | 0.96 | 0.58-1.60 | 0.89 | |||
Diabetes | 0.81 | 0.52-1.26 | 0.36 | |||
Symptoms of CRC | 0.90 | 0.68-1.19 | 0.65 |
- Citation: Rattan N, Willmann L, Aston D, George S, Bassan M, Abi-Hanna D, Anandabaskaran S, Ermerak G, Ng W, Koo JH. To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy. World J Gastrointest Oncol 2022; 14(9): 1798-1807
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1798.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1798